Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer

7 May 2021

Abstract excerpt

BACKGROUND: Bladder cancer is the leading causes of cancer-associated mortality and seriously affects population health. Hypoxia plays a key role in tumor development and immune escape, which contributes to malignant behaviors. METHODS: In this study, we analyzed the RNA-seq and clinical information of bladder cancer patients from The Cancer Genome Atlas (TCGA) database. To investigate the hypoxia-related...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33962639
DOI: 10.1186/s12935-021-01954-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancerPMID 33962639Read ↗

Identification and Validation of A Hypoxia-Related Prognostic and Immune Microenvironment Signature in Bladder CancerSemantic proximity Read ↗

Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in bladder cancerSemantic proximity Read ↗

Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in BLCASemantic proximity Read ↗

TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancerSemantic proximity Read ↗

Hypoxia score for predicting prognosis and tumor response to immunotherapy in bladder urothelial carcinomaSemantic proximity Read ↗

Hypoxia-related Genes as Prognostic Signature to Predict Prognosis and Immune Microenvironment of Colorectal Cancer PatientsSemantic proximity Read ↗

Development of A Prognostic Index and Screening of Prognosis Related Genes Based on an Immunogenomic Landscape Analysis of Bladder CancerSemantic proximity Read ↗

Integrative analysis of immune molecular subtypes and microenvironment characteristics of bladder cancer.Semantic proximity Read ↗

Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancerSemantic proximity Read ↗

Development And Validation of A Novel Hypoxia- And Immune-Related Prognostic Signature For Bone And Soft Tissue Sarcoma PatientsSemantic proximity Read ↗

Identification of Microenvironment-Related Prognostic Genes in Bladder Cancer Based on Gene Expression ProfileSemantic proximity Read ↗

New exploration of bladder cancer-related immune gene biomarkers in predicting the prognosis of urinary system tumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.